Showing results (1601-1610 of 3,638) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|November 7, 2012
Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic featuresAggelos Laliotis, Thomas Vrekoussis, Maria Kafousi, et al.
Breast (Edinburgh, Scotland)|May 20, 2014
A phase 1/2 of a combination of cetuximab and taxane for "triple negative" breast cancer patientsHovav Nechushtan, Gilad Vainer, Hana Stainberg, et al.
Breast (Edinburgh, Scotland)|August 15, 2022
Survival in HIV+ and HIV- women with breast cancer treated at the National Cancer Institute in the city of Rio de Janeiro, Brazil, between 2000 and 2014Mariana Pinto Ferreira, Luiz Claudio Santos Thuler, Marcelo A Soares, et al.
Breast (Edinburgh, Scotland)|August 4, 2022
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNABinliang Liu, Zheyu Hu, Jialu Ran, et al.
Breast (Edinburgh, Scotland)|August 9, 2022
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational studyAntoine Vasseur, Matthieu Carton, Severine Guiu, et al.
Breast (Edinburgh, Scotland)|May 2, 2021
Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testingJeanine A M van der Giessen, Sandra van Dulmen, Mary E Velthuizen, et al.
Breast (Edinburgh, Scotland)|June 9, 2020
Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patientsXingxia Yang, Jiahui Huang, Xiaoping Zhu, et al.
Breast (Edinburgh, Scotland)|June 3, 2020
Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillanceJ X Hing, C W Mok, P T Tan, et al.
Breast (Edinburgh, Scotland)|June 8, 2020
The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trialLeonard R, Yellowlees A, Mansi J, et al.
Breast (Edinburgh, Scotland)|May 26, 2020
A multi-stakeholder approach in optimising patients' needs in the benefit assessment process of new metastatic breast cancer treatmentsFatima Cardoso, Nils Wilking, Renato Bernardini, et al.
Pageof 364